At Kymos Group, we continuously expand our analytical capabilities to support and match the needs of the pharmaceutical and biotech industries with state-of-the-art quality control solutions. Endotoxin testing is crucial when dealing with the safety of injectables, biologics, and medical devices, and we have updated our catalog of services to offer the full range (...) Read more
Denosumab represents one of the leading biologics applied today in various diseases of bones: treatment and prevention of osteoporosis, bone metastases, and other skeletal disorders. Its success in improving patient health has made it one of the most impactful therapies in its field. With the growth of the biosimilar market in recent years and (...) Read more
Liraglutide and Semaglutide have become key players in the pharmaceutical and healthcare industry as they are both being used and have been approved not only as an anti-diabetic medication but also as an obesity and weight loss treatment. In combination with the huge growth of the biosimilar market in recent years and their patent expiry (...) Read more
